nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxylamine—CHRM1—Monoamine GPCRs—DRD2—bipolar disorder	0.0126	0.0142	CbGpPWpGaD
Doxylamine—HRH1—Amine ligand-binding receptors—HTR1A—bipolar disorder	0.0126	0.0141	CbGpPWpGaD
Doxylamine—CHRM1—Amine ligand-binding receptors—HTR1A—bipolar disorder	0.0125	0.0141	CbGpPWpGaD
Doxylamine—HRH1—GPCRs, Class A Rhodopsin-like—GPR50—bipolar disorder	0.0124	0.014	CbGpPWpGaD
Doxylamine—CHRM1—GPCRs, Class A Rhodopsin-like—GPR50—bipolar disorder	0.0124	0.0139	CbGpPWpGaD
Doxylamine—HRH1—Amine ligand-binding receptors—DRD1—bipolar disorder	0.0121	0.0136	CbGpPWpGaD
Doxylamine—HRH1—Amine ligand-binding receptors—HTR2C—bipolar disorder	0.0121	0.0136	CbGpPWpGaD
Doxylamine—CHRM1—Amine ligand-binding receptors—DRD1—bipolar disorder	0.0121	0.0136	CbGpPWpGaD
Doxylamine—CHRM1—Amine ligand-binding receptors—HTR2C—bipolar disorder	0.0121	0.0136	CbGpPWpGaD
Doxylamine—HRH1—Amine ligand-binding receptors—DRD3—bipolar disorder	0.0117	0.0132	CbGpPWpGaD
Doxylamine—CHRM1—Amine ligand-binding receptors—DRD3—bipolar disorder	0.0117	0.0132	CbGpPWpGaD
Doxylamine—HRH1—Amine ligand-binding receptors—DRD4—bipolar disorder	0.0114	0.0128	CbGpPWpGaD
Doxylamine—CHRM1—Amine ligand-binding receptors—DRD4—bipolar disorder	0.0114	0.0128	CbGpPWpGaD
Doxylamine—Orphenadrine—GRIN1—bipolar disorder	0.0111	0.1	CrCbGaD
Doxylamine—Amitriptyline—NTRK2—bipolar disorder	0.0111	0.1	CrCbGaD
Doxylamine—HRH1—Amine ligand-binding receptors—DRD2—bipolar disorder	0.0106	0.0119	CbGpPWpGaD
Doxylamine—CHRM1—Amine ligand-binding receptors—DRD2—bipolar disorder	0.0106	0.0119	CbGpPWpGaD
Doxylamine—HRH1—IL-4 Signaling Pathway—GATA3—bipolar disorder	0.00972	0.0109	CbGpPWpGaD
Doxylamine—HRH1—Monoamine GPCRs—HTR2A—bipolar disorder	0.00885	0.00995	CbGpPWpGaD
Doxylamine—CHRM1—Monoamine GPCRs—HTR2A—bipolar disorder	0.00882	0.00992	CbGpPWpGaD
Doxylamine—CHRM1—Calcium Regulation in the Cardiac Cell—RGS4—bipolar disorder	0.00749	0.00843	CbGpPWpGaD
Doxylamine—HRH1—Amine ligand-binding receptors—HTR2A—bipolar disorder	0.00744	0.00836	CbGpPWpGaD
Doxylamine—CHRM1—Amine ligand-binding receptors—HTR2A—bipolar disorder	0.00741	0.00834	CbGpPWpGaD
Doxylamine—HRH1—G alpha (q) signalling events—DGKH—bipolar disorder	0.00699	0.00786	CbGpPWpGaD
Doxylamine—CHRM1—G alpha (q) signalling events—DGKH—bipolar disorder	0.00697	0.00784	CbGpPWpGaD
Doxylamine—Amitriptyline—NTRK1—bipolar disorder	0.00686	0.0618	CrCbGaD
Doxylamine—CHRM1—Circadian rythm related genes—NR1D1—bipolar disorder	0.00642	0.00722	CbGpPWpGaD
Doxylamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—bipolar disorder	0.00625	0.00703	CbGpPWpGaD
Doxylamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—bipolar disorder	0.00623	0.00701	CbGpPWpGaD
Doxylamine—Chlorphenamine—SLC6A3—bipolar disorder	0.00503	0.0453	CrCbGaD
Doxylamine—HRH1—GPCRs, Class A Rhodopsin-like—DRD5—bipolar disorder	0.00494	0.00556	CbGpPWpGaD
Doxylamine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD5—bipolar disorder	0.00492	0.00554	CbGpPWpGaD
Doxylamine—CHRM1—Calcium Regulation in the Cardiac Cell—CACNA1C—bipolar disorder	0.00492	0.00554	CbGpPWpGaD
Doxylamine—HRH1—G alpha (q) signalling events—TRPC3—bipolar disorder	0.00484	0.00545	CbGpPWpGaD
Doxylamine—CHRM1—G alpha (q) signalling events—TRPC3—bipolar disorder	0.00483	0.00543	CbGpPWpGaD
Doxylamine—CHRM1—Regulation of Actin Cytoskeleton—PIK3C2A—bipolar disorder	0.0048	0.0054	CbGpPWpGaD
Doxylamine—HRH1—G alpha (q) signalling events—TACR1—bipolar disorder	0.0045	0.00507	CbGpPWpGaD
Doxylamine—CHRM1—G alpha (q) signalling events—TACR1—bipolar disorder	0.00449	0.00505	CbGpPWpGaD
Doxylamine—CHRM1—Circadian rythm related genes—CLOCK—bipolar disorder	0.00435	0.00489	CbGpPWpGaD
Doxylamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC3—bipolar disorder	0.00433	0.00487	CbGpPWpGaD
Doxylamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TRPC3—bipolar disorder	0.00432	0.00486	CbGpPWpGaD
Doxylamine—Benzphetamine—SLC6A3—bipolar disorder	0.00426	0.0384	CrCbGaD
Doxylamine—CHRM1—Circadian rythm related genes—TPH2—bipolar disorder	0.00424	0.00477	CbGpPWpGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD5—bipolar disorder	0.00423	0.00476	CbGpPWpGaD
Doxylamine—Atomoxetine—SLC6A3—bipolar disorder	0.00423	0.0381	CrCbGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD5—bipolar disorder	0.00422	0.00475	CbGpPWpGaD
Doxylamine—Cyclobenzaprine—HTR2A—bipolar disorder	0.00413	0.0372	CrCbGaD
Doxylamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TACR1—bipolar disorder	0.00403	0.00453	CbGpPWpGaD
Doxylamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TACR1—bipolar disorder	0.00401	0.00452	CbGpPWpGaD
Doxylamine—Atomoxetine—HTR2C—bipolar disorder	0.00381	0.0343	CrCbGaD
Doxylamine—CHRM1—Calcium Regulation in the Cardiac Cell—ADCY2—bipolar disorder	0.00381	0.00428	CbGpPWpGaD
Doxylamine—Chlorphenamine—SLC6A4—bipolar disorder	0.00376	0.0339	CrCbGaD
Doxylamine—HRH1—G alpha (q) signalling events—TAC1—bipolar disorder	0.00367	0.00413	CbGpPWpGaD
Doxylamine—Promazine—DRD4—bipolar disorder	0.00367	0.033	CrCbGaD
Doxylamine—CHRM1—G alpha (q) signalling events—TAC1—bipolar disorder	0.00366	0.00412	CbGpPWpGaD
Doxylamine—HRH1—G alpha (q) signalling events—HTR2C—bipolar disorder	0.0036	0.00405	CbGpPWpGaD
Doxylamine—CHRM1—G alpha (q) signalling events—HTR2C—bipolar disorder	0.00359	0.00404	CbGpPWpGaD
Doxylamine—CHRM1—Circadian rythm related genes—SLC6A4—bipolar disorder	0.00339	0.00381	CbGpPWpGaD
Doxylamine—CHRM1—Circadian rythm related genes—DRD1—bipolar disorder	0.00339	0.00381	CbGpPWpGaD
Doxylamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—bipolar disorder	0.00328	0.00369	CbGpPWpGaD
Doxylamine—CHRM1—Circadian rythm related genes—DRD3—bipolar disorder	0.00328	0.00369	CbGpPWpGaD
Doxylamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—bipolar disorder	0.00327	0.00368	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—DRD5—bipolar disorder	0.00322	0.00363	CbGpPWpGaD
Doxylamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—bipolar disorder	0.00322	0.00362	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—DRD5—bipolar disorder	0.00321	0.00361	CbGpPWpGaD
Doxylamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2C—bipolar disorder	0.00321	0.00361	CbGpPWpGaD
Doxylamine—CHRM1—Circadian rythm related genes—DRD4—bipolar disorder	0.00318	0.00358	CbGpPWpGaD
Doxylamine—Atomoxetine—SLC6A4—bipolar disorder	0.00316	0.0285	CrCbGaD
Doxylamine—Promazine—DRD1—bipolar disorder	0.00311	0.028	CrCbGaD
Doxylamine—Doxepin—HTR2C—bipolar disorder	0.00299	0.0269	CrCbGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—TSHB—bipolar disorder	0.00298	0.00335	CbGpPWpGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—TACR1—bipolar disorder	0.00298	0.00335	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—TSHB—bipolar disorder	0.00297	0.00334	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—TACR1—bipolar disorder	0.00297	0.00334	CbGpPWpGaD
Doxylamine—CHRM1—Circadian rythm related genes—DRD2—bipolar disorder	0.00297	0.00334	CbGpPWpGaD
Doxylamine—Doxepin—HTR1A—bipolar disorder	0.0029	0.0261	CrCbGaD
Doxylamine—HRH1—GPCRs, Class A Rhodopsin-like—HTR1A—bipolar disorder	0.00288	0.00324	CbGpPWpGaD
Doxylamine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR1A—bipolar disorder	0.00287	0.00323	CbGpPWpGaD
Doxylamine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2C—bipolar disorder	0.00278	0.00313	CbGpPWpGaD
Doxylamine—HRH1—GPCRs, Class A Rhodopsin-like—DRD1—bipolar disorder	0.00278	0.00313	CbGpPWpGaD
Doxylamine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD1—bipolar disorder	0.00277	0.00312	CbGpPWpGaD
Doxylamine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2C—bipolar disorder	0.00277	0.00312	CbGpPWpGaD
Doxylamine—Amitriptyline—DRD3—bipolar disorder	0.00275	0.0248	CrCbGaD
Doxylamine—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—bipolar disorder	0.0027	0.00303	CbGpPWpGaD
Doxylamine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD3—bipolar disorder	0.00269	0.00302	CbGpPWpGaD
Doxylamine—CHRM1—Circadian rythm related genes—NTRK1—bipolar disorder	0.00269	0.00302	CbGpPWpGaD
Doxylamine—Promazine—HTR2C—bipolar disorder	0.00266	0.0239	CrCbGaD
Doxylamine—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—bipolar disorder	0.00262	0.00294	CbGpPWpGaD
Doxylamine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—bipolar disorder	0.00261	0.00293	CbGpPWpGaD
Doxylamine—Imipramine—SLC6A3—bipolar disorder	0.00258	0.0232	CrCbGaD
Doxylamine—Doxepin—SLC6A4—bipolar disorder	0.00248	0.0223	CrCbGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1A—bipolar disorder	0.00247	0.00278	CbGpPWpGaD
Doxylamine—Doxepin—DRD2—bipolar disorder	0.00246	0.0222	CrCbGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR1A—bipolar disorder	0.00246	0.00277	CbGpPWpGaD
Doxylamine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—bipolar disorder	0.00244	0.00274	CbGpPWpGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—TAC1—bipolar disorder	0.00243	0.00273	CbGpPWpGaD
Doxylamine—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—bipolar disorder	0.00243	0.00273	CbGpPWpGaD
Doxylamine—Atomoxetine—HTR2A—bipolar disorder	0.00243	0.0219	CrCbGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—bipolar disorder	0.00242	0.00273	CbGpPWpGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD1—bipolar disorder	0.00238	0.00268	CbGpPWpGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2C—bipolar disorder	0.00238	0.00268	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD1—bipolar disorder	0.00238	0.00267	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2C—bipolar disorder	0.00238	0.00267	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—ADM—bipolar disorder	0.00233	0.00262	CbGpPWpGaD
Doxylamine—Imipramine—HTR2C—bipolar disorder	0.00233	0.021	CrCbGaD
Doxylamine—CHRM1—GPCR ligand binding—ADM—bipolar disorder	0.00232	0.00261	CbGpPWpGaD
Doxylamine—Amitriptyline—HTR2C—bipolar disorder	0.00231	0.0208	CrCbGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—bipolar disorder	0.00231	0.0026	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—bipolar disorder	0.0023	0.00259	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—TSHB—bipolar disorder	0.00227	0.00255	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—TACR1—bipolar disorder	0.00227	0.00255	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—TSHB—bipolar disorder	0.00226	0.00255	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—TACR1—bipolar disorder	0.00226	0.00255	CbGpPWpGaD
Doxylamine—Imipramine—HTR1A—bipolar disorder	0.00226	0.0203	CrCbGaD
Doxylamine—Amitriptyline—HTR1A—bipolar disorder	0.00224	0.0202	CrCbGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—bipolar disorder	0.00224	0.00252	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—bipolar disorder	0.00223	0.00251	CbGpPWpGaD
Doxylamine—HRH1—G alpha (q) signalling events—HTR2A—bipolar disorder	0.00221	0.00248	CbGpPWpGaD
Doxylamine—CHRM1—G alpha (q) signalling events—HTR2A—bipolar disorder	0.0022	0.00248	CbGpPWpGaD
Doxylamine—Promazine—DRD2—bipolar disorder	0.00219	0.0197	CrCbGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—bipolar disorder	0.00209	0.00235	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—bipolar disorder	0.00208	0.00234	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—DGKH—bipolar disorder	0.00199	0.00224	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—DGKH—bipolar disorder	0.00199	0.00223	CbGpPWpGaD
Doxylamine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—bipolar disorder	0.00198	0.00222	CbGpPWpGaD
Doxylamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—bipolar disorder	0.00197	0.00221	CbGpPWpGaD
Doxylamine—Imipramine—SLC6A4—bipolar disorder	0.00193	0.0174	CrCbGaD
Doxylamine—Imipramine—DRD2—bipolar disorder	0.00192	0.0173	CrCbGaD
Doxylamine—Amitriptyline—SLC6A4—bipolar disorder	0.00192	0.0173	CrCbGaD
Doxylamine—Amitriptyline—DRD2—bipolar disorder	0.0019	0.0172	CrCbGaD
Doxylamine—Doxepin—HTR2A—bipolar disorder	0.0019	0.0171	CrCbGaD
Doxylamine—HRH1—GPCR ligand binding—HTR1A—bipolar disorder	0.00188	0.00211	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—HTR1A—bipolar disorder	0.00187	0.00211	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—TAC1—bipolar disorder	0.00185	0.00208	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—TAC1—bipolar disorder	0.00185	0.00208	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—DRD5—bipolar disorder	0.00182	0.00205	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—DRD5—bipolar disorder	0.00182	0.00204	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—DRD1—bipolar disorder	0.00182	0.00204	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—HTR2C—bipolar disorder	0.00182	0.00204	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—HTR2C—bipolar disorder	0.00181	0.00204	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—DRD1—bipolar disorder	0.00181	0.00204	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—DGKH—bipolar disorder	0.00181	0.00203	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—DGKH—bipolar disorder	0.0018	0.00203	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—RGS4—bipolar disorder	0.00179	0.00201	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—RGS4—bipolar disorder	0.00178	0.002	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—DRD3—bipolar disorder	0.00176	0.00198	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—DRD3—bipolar disorder	0.00175	0.00197	CbGpPWpGaD
Doxylamine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	0.00171	0.00192	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—DRD4—bipolar disorder	0.00171	0.00192	CbGpPWpGaD
Doxylamine—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—bipolar disorder	0.0017	0.00191	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—DRD4—bipolar disorder	0.0017	0.00191	CbGpPWpGaD
Doxylamine—Promazine—HTR2A—bipolar disorder	0.00169	0.0152	CrCbGaD
Doxylamine—CHRM1—Circadian rythm related genes—GSK3B—bipolar disorder	0.00167	0.00188	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—DRD5—bipolar disorder	0.00165	0.00186	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—DRD5—bipolar disorder	0.00165	0.00185	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—RGS4—bipolar disorder	0.00162	0.00182	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—RGS4—bipolar disorder	0.00162	0.00182	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—DRD2—bipolar disorder	0.00159	0.00179	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—DRD2—bipolar disorder	0.00159	0.00178	CbGpPWpGaD
Doxylamine—Imipramine—HTR2A—bipolar disorder	0.00148	0.0133	CrCbGaD
Doxylamine—Amitriptyline—HTR2A—bipolar disorder	0.00147	0.0133	CrCbGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	0.00146	0.00165	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—bipolar disorder	0.00146	0.00164	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—TRPC3—bipolar disorder	0.00138	0.00155	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—TRPC3—bipolar disorder	0.00138	0.00155	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—ADM—bipolar disorder	0.00132	0.00148	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—ADM—bipolar disorder	0.00131	0.00148	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—TSHB—bipolar disorder	0.00128	0.00144	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—PDE4B—bipolar disorder	0.00128	0.00144	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—TACR1—bipolar disorder	0.00128	0.00144	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—TSHB—bipolar disorder	0.00128	0.00144	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—PDE4B—bipolar disorder	0.00128	0.00144	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—TACR1—bipolar disorder	0.00128	0.00144	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—TRPC3—bipolar disorder	0.00125	0.00141	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—TRPC3—bipolar disorder	0.00125	0.00141	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—ADM—bipolar disorder	0.0012	0.00135	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—ADM—bipolar disorder	0.00119	0.00134	CbGpPWpGaD
Doxylamine—HRH1—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	0.00117	0.00131	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—TSHB—bipolar disorder	0.00117	0.00131	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—TACR1—bipolar disorder	0.00117	0.00131	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—PDE4B—bipolar disorder	0.00117	0.00131	CbGpPWpGaD
Doxylamine—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—bipolar disorder	0.00116	0.00131	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—PDE4B—bipolar disorder	0.00116	0.00131	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—TSHB—bipolar disorder	0.00116	0.00131	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—TACR1—bipolar disorder	0.00116	0.00131	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—AKR1C4—bipolar disorder	0.00116	0.00131	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—AKR1C4—bipolar disorder	0.00116	0.0013	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—HTR2A—bipolar disorder	0.00111	0.00125	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—HTR2A—bipolar disorder	0.00111	0.00125	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—DGKH—bipolar disorder	0.00107	0.0012	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—DGKH—bipolar disorder	0.00107	0.0012	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—HTR1A—bipolar disorder	0.00106	0.0012	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—HTR1A—bipolar disorder	0.00106	0.00119	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—TAC1—bipolar disorder	0.00105	0.00118	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—TAC1—bipolar disorder	0.00104	0.00117	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—HTR2C—bipolar disorder	0.00103	0.00115	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—DRD1—bipolar disorder	0.00103	0.00115	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—DRD1—bipolar disorder	0.00102	0.00115	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—HTR2C—bipolar disorder	0.00102	0.00115	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—DRD3—bipolar disorder	0.000994	0.00112	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—DRD3—bipolar disorder	0.000991	0.00111	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—DRD5—bipolar disorder	0.000977	0.0011	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—DRD5—bipolar disorder	0.000974	0.0011	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—HTR1A—bipolar disorder	0.000965	0.00109	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—DRD4—bipolar disorder	0.000965	0.00109	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—HTR1A—bipolar disorder	0.000962	0.00108	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—DRD4—bipolar disorder	0.000962	0.00108	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—RGS4—bipolar disorder	0.000958	0.00108	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—RGS4—bipolar disorder	0.000955	0.00107	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—TAC1—bipolar disorder	0.00095	0.00107	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—TAC1—bipolar disorder	0.000947	0.00107	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—HTR2C—bipolar disorder	0.000932	0.00105	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—DRD1—bipolar disorder	0.000932	0.00105	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—HTR2C—bipolar disorder	0.000929	0.00104	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—DRD1—bipolar disorder	0.000929	0.00104	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—ADCY2—bipolar disorder	0.000908	0.00102	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—ADCY2—bipolar disorder	0.000905	0.00102	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—DRD3—bipolar disorder	0.000902	0.00102	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—DRD3—bipolar disorder	0.0009	0.00101	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—DRD2—bipolar disorder	0.000899	0.00101	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—DRD2—bipolar disorder	0.000896	0.00101	CbGpPWpGaD
Doxylamine—HRH1—GPCR ligand binding—POMC—bipolar disorder	0.00089	0.001	CbGpPWpGaD
Doxylamine—CHRM1—GPCR ligand binding—POMC—bipolar disorder	0.000887	0.000997	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—DRD4—bipolar disorder	0.000876	0.000985	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—DRD4—bipolar disorder	0.000873	0.000982	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—ADCY2—bipolar disorder	0.000825	0.000928	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—ADCY2—bipolar disorder	0.000822	0.000925	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—DRD2—bipolar disorder	0.000816	0.000918	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—DRD2—bipolar disorder	0.000813	0.000915	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—TRPC3—bipolar disorder	0.000741	0.000833	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—TRPC3—bipolar disorder	0.000738	0.00083	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—ADM—bipolar disorder	0.000707	0.000795	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—ADM—bipolar disorder	0.000704	0.000792	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—TSHB—bipolar disorder	0.000689	0.000774	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—PDE4B—bipolar disorder	0.000689	0.000774	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—TACR1—bipolar disorder	0.000689	0.000774	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—TSHB—bipolar disorder	0.000686	0.000772	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—PDE4B—bipolar disorder	0.000686	0.000772	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—TACR1—bipolar disorder	0.000686	0.000772	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—HTR2A—bipolar disorder	0.000629	0.000708	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—HTR2A—bipolar disorder	0.000627	0.000706	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—HTR2A—bipolar disorder	0.000572	0.000643	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—HTR1A—bipolar disorder	0.00057	0.000641	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—HTR2A—bipolar disorder	0.00057	0.000641	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—HTR1A—bipolar disorder	0.000568	0.000639	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—TAC1—bipolar disorder	0.000561	0.000631	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—TAC1—bipolar disorder	0.000559	0.000629	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—DRD1—bipolar disorder	0.00055	0.000619	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—HTR2C—bipolar disorder	0.00055	0.000619	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—HTR2C—bipolar disorder	0.000549	0.000617	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—DRD1—bipolar disorder	0.000549	0.000617	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—NTRK2—bipolar disorder	0.000535	0.000602	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—NTRK2—bipolar disorder	0.000534	0.0006	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—DRD3—bipolar disorder	0.000533	0.0006	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—DRD3—bipolar disorder	0.000531	0.000598	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—GSK3A—bipolar disorder	0.000531	0.000597	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—GSK3A—bipolar disorder	0.000529	0.000595	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—DRD4—bipolar disorder	0.000518	0.000582	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—DRD4—bipolar disorder	0.000516	0.00058	CbGpPWpGaD
Doxylamine—HRH1—GPCR downstream signaling—POMC—bipolar disorder	0.000503	0.000565	CbGpPWpGaD
Doxylamine—CHRM1—GPCR downstream signaling—POMC—bipolar disorder	0.000501	0.000564	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—ADCY2—bipolar disorder	0.000487	0.000548	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—ADCY2—bipolar disorder	0.000486	0.000546	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—TCF7L2—bipolar disorder	0.000485	0.000546	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—TCF7L2—bipolar disorder	0.000484	0.000544	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—DRD2—bipolar disorder	0.000482	0.000542	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—DRD2—bipolar disorder	0.000481	0.000541	CbGpPWpGaD
Doxylamine—HRH1—Signaling by GPCR—POMC—bipolar disorder	0.000456	0.000513	CbGpPWpGaD
Doxylamine—CHRM1—Signaling by GPCR—POMC—bipolar disorder	0.000455	0.000512	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—NTRK1—bipolar disorder	0.000436	0.000491	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—NTRK1—bipolar disorder	0.000435	0.000489	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—S100B—bipolar disorder	0.000424	0.000477	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—S100B—bipolar disorder	0.000423	0.000476	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—NRG1—bipolar disorder	0.000374	0.000421	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—NRG1—bipolar disorder	0.000373	0.00042	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—HTR2A—bipolar disorder	0.000338	0.00038	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—HTR2A—bipolar disorder	0.000337	0.000379	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—GSK3B—bipolar disorder	0.000272	0.000306	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—GSK3B—bipolar disorder	0.000271	0.000305	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—POMC—bipolar disorder	0.00027	0.000303	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—POMC—bipolar disorder	0.000269	0.000302	CbGpPWpGaD
Doxylamine—HRH1—Signaling Pathways—INS—bipolar disorder	0.000268	0.000302	CbGpPWpGaD
Doxylamine—CHRM1—Signaling Pathways—INS—bipolar disorder	0.000267	0.000301	CbGpPWpGaD
